← Leaderboards
Alan S Verkman
University Of California San Francisco
$35,167,321
Attributed
$35,167,321
Total exposure
34
Grants
27
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.5M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$53,237,503 · 35
By mechanism
P30$25,686,668 · 22
R01$18,063,589 · 7
R37$8,297,341 · 2
RC1$989,235 · 1
P50$180,910 · 1
P41$19,760 · 2
Top collaborators
- Peter Michael Haggie1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSmall MoleculeCystic Fibrosis Transmembrane Conductance RegulatorHigh Throughput ScreeningCystic FibrosisWater ChannelTissuesPharmaceutical PreparationsBaseResearch PersonnelInhibitor/AntagonistMeasurementFundingProgramsEvaluationEpithelial CellsMolecularCell ModelLiquid SubstanceIn VivoPropertyFluorescencePilot ProjectsLead
Grant awards (155)
Novel small-molecule therapies for CF$635,784
P30 · FY2022 · DK · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$391,638
R01 · FY2022 · EY · contact PI
Core A: High-Throughput Screening Core$179,864
P30 · FY2022 · DK · contact PI
Pilot & Feasibility Program$105,008
P30 · FY2022 · DK · contact PI
Core C: Chemistry Core$78,506
P30 · FY2022 · DK · contact PI
Administrative Core$13,789
P30 · FY2022 · DK · contact PI
Novel small-molecule therapies for CF$637,418
P30 · FY2021 · DK · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$391,637
R01 · FY2021 · EY · contact PI
Core A: High-Throughput Screening Core$183,094
P30 · FY2021 · DK · contact PI
Pilot & Feasibility Program$105,009
P30 · FY2021 · DK · contact PI
Core C: Chemistry Core$78,394
P30 · FY2021 · DK · contact PI
Administrative Core$13,789
P30 · FY2021 · DK · contact PI
Novel small-molecule therapies for CF$584,722
P30 · FY2020 · DK · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$403,334
R01 · FY2020 · EY · contact PI
Core A: High-Throughput Screening Core$183,385
P30 · FY2020 · DK · contact PI
Pilot & Feasibility Program$105,008
P30 · FY2020 · DK · contact PI
Core C: Chemistry Core$56,757
P30 · FY2020 · DK · contact PI
Administrative Core$13,789
P30 · FY2020 · DK · contact PI
Novel Small-Molecule Therapies for CF$970,729
P30 · FY2019 · DK · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$401,041
R01 · FY2019 · EY · contact PI
High-Throughput Screening$285,287
P30 · FY2019 · DK · contact PI
Pilot & Feasibility$191,018
P30 · FY2019 · DK · contact PI
Administrative Core$52,552
P30 · FY2019 · DK · contact PI
Novel Small-Molecule Therapies for CF$985,620
P30 · FY2018 · DK · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$399,792
R01 · FY2018 · EY · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$392,403
R01 · FY2018 · EY · contact PI
Urea transport inhibitors as a new class of diuretics$342,780
R01 · FY2018 · DK · contact PI
High-Throughput Screening$274,544
P30 · FY2018 · DK · contact PI
Pilot & Feasibility$221,301
P30 · FY2018 · DK · contact PI
Administrative Core$204,483
P30 · FY2018 · DK · contact PI
Novel Small-Molecule Therapies for CF$1,006,208
P30 · FY2017 · DK · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$396,250
R01 · FY2017 · EY · contact PI
Urea transport inhibitors as a new class of diuretics$342,780
R01 · FY2017 · DK · contact PI
High-Throughput Screening$283,081
P30 · FY2017 · DK · contact PI
Pilot & Feasibility$221,325
P30 · FY2017 · DK · contact PI
Administrative Core$208,807
P30 · FY2017 · DK · contact PI
Novel Small-Molecule Therapies for CF$1,021,850
P30 · FY2016 · DK · contact PI
Application of Novel Optical Methods to Cell Dynamics$424,875
R37 · FY2016 · EB · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$396,250
R01 · FY2016 · EY · contact PI
Urea transport inhibitors as a new class of diuretics$342,780
R01 · FY2016 · DK · contact PI
High-Throughput Screening$291,014
P30 · FY2016 · DK · contact PI
Pilot & Feasibility$221,612
P30 · FY2016 · DK · contact PI
Administrative Core$208,229
P30 · FY2016 · DK · contact PI
Novel small-molecule therapies for CF$1,150,450
P30 · FY2015 · DK · contact PI
Application of Novel Optical Methods to Cell Dynamics$416,377
R37 · FY2015 · EB · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$388,119
R01 · FY2015 · EY · contact PI
Urea transport inhibitors as a new class of diuretics$342,563
R01 · FY2015 · DK · contact PI
High-Throughput Screening$337,705
P30 · FY2015 · DK · contact PI
Administrative Core$256,631
P30 · FY2015 · DK · contact PI
Pilot & Feasibility$221,842
P30 · FY2015 · DK · contact PI
Novel Small-Molecule Therapies for CF$1,092,849
P30 · FY2014 · DK · contact PI
Application of Novel Optical Methods to Cell Dynamics$412,129
R37 · FY2014 · EB · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$386,692
R01 · FY2014 · EY · contact PI
Urea transport inhibitors as a new class of diuretics$355,913
R01 · FY2014 · DK · contact PI
Mechanisms of water transport in renal epithelia$336,038
R01 · FY2014 · DK · contact PI
Novel Small-Molecule Therapies for CF$1,045,840
P30 · FY2013 · DK · contact PI
Application of Novel Optical Methods to Cell Dynamics$400,658
R37 · FY2013 · EB · contact PI
Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies$392,291
R01 · FY2013 · EY · contact PI
Mechanisms of water transport in renal epithelia$324,277
R01 · FY2013 · DK · contact PI
Novel Small-Molecule Therapies for CF$1,124,794
P30 · FY2012 · DK · contact PI
Application of Novel Optical Methods to Cell Dynamics$466,875
R37 · FY2012 · EB · contact PI
Mechanisms of water transport in renal epithelia$336,038
R01 · FY2012 · DK · contact PI
Core E Haggie Bioassays Core$160,693
P30 · FY2012 · DK · contact PI
Composite budget Verkman$160,692
P30 · FY2012 · DK · contact PI
Core C finkbeiner Cell Models Core$160,692
P30 · FY2012 · DK · contact PI
Core B Nielson Clinical Materials Core$160,692
P30 · FY2012 · DK · contact PI
Core A Verkman Screening Core$160,692
P30 · FY2012 · DK · contact PI
Admin Core Verkman$160,692
P30 · FY2012 · DK · contact PI
Core D Kurth Synthesis Core$160,641
P30 · FY2012 · DK · contact PI
Novel Small-Molecule Therapies for CF$1,140,903
P30 · FY2011 · DK · contact PI
Mechanisms of water transport in renal epithelia$386,250
R01 · FY2011 · DK · contact PI
Application of Novel Optial Methods to Cell Dynamics$365,824
R37 · FY2011 · EB · contact PI
Functional Role of Aquaporins in Eye Physiology$330,383
R01 · FY2011 · EY · contact PI
Novel small-molecule therapies for CF$1,154,801
P30 · FY2010 · DK · contact PI
CFTR inhibitors for therapy of polycystic kidney disease$498,694
RC1 · FY2010 · DK · contact PI
Role of airway submucosal glands in CF lung disease$386,250
R01 · FY2010 · HL · contact PI
Application of Novel Optial Methods to Cell Dynamics$380,591
R37 · FY2010 · EB · contact PI
Functional Role of Aquaporins in Eye Physiology$344,149
R01 · FY2010 · EY · contact PI
Novel small-molecule therapies for CF$215,875
P30 · FY2010 · DK · contact PI
Novel small-molecule therapies for CF$1,036,332
P30 · FY2009 · DK · contact PI
CFTR inhibitors for therapy of polycystic kidney disease$490,541
RC1 · FY2009 · DK · contact PI
Role of airway submucosal glands in CF lung disease$386,250
R01 · FY2009 · HL · contact PI
Application of Novel Optial Methods to Cell Dynamics$384,435
R37 · FY2009 · EB · contact PI
Functional Role of Aquaporins in Eye Physiology$347,625
R01 · FY2009 · EY · contact PI
CORE--HIGH-THROUGHPUT SCREENING$175,688
P30 · FY2009 · DK · contact PI
Novel small-molecule therapies for CF$96,176
P30 · FY2009 · DK · contact PI
CORE--MOUSE MODELS$80,526
P30 · FY2009 · DK · contact PI
Pilot 2$73,204
P30 · FY2009 · DK · contact PI
Novel small-molecule therapies for CF$1,035,766
P30 · FY2008 · DK · contact PI
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$521,334
R37 · FY2008 · DK · contact PI
Role of airway submucosal glands in CF lung disease$386,250
R01 · FY2008 · HL · contact PI
Application of Novel Optial Methods to Cell Dynamics$384,123
R37 · FY2008 · EB · contact PI
Functional Role of Aquaporins in Eye Physiology$340,673
R01 · FY2008 · EY · contact PI
CORE--HIGH-THROUGHPUT SCREENING$175,592
P30 · FY2008 · DK · contact PI
CORE--MOUSE MODELS$80,481
P30 · FY2008 · DK · contact PI
Pilot 2$73,167
P30 · FY2008 · DK · contact PI
Novel small-molecule therapies for CF$997,891
P30 · FY2007 · DK · contact PI
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$521,060
R37 · FY2007 · DK · contact PI
Role of airway submucosal glands in CF lung disease$385,209
R01 · FY2007 · HL · contact PI
Application of Novel Optial Methods to Cell Dynamics$384,688
R37 · FY2007 · EB · contact PI
Functional Role of Aquaporins in Eye Physiology$346,688
R01 · FY2007 · EY · contact PI
Physiology and Molecular Biology of Lung Water Transport$323,210
R01 · FY2007 · HL · contact PI
CORE--HIGH-THROUGHPUT SCREENING$183,862
P30 · FY2007 · DK · contact PI
Administrative Core$120,618
P30 · FY2007 · DK · contact PI
CORE--MOUSE MODELS$87,489
P30 · FY2007 · DK · contact PI
Pilot 2$79,398
P30 · FY2007 · DK · contact PI
Application of Novel Optial Methods to Cell Dynamics$72,550
R37 · FY2007 · EB · contact PI
Novel small-molecule therapies for CF$1,032,900
P30 · FY2006 · DK · contact PI
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$525,650
R37 · FY2006 · DK · contact PI
Role of ASL and Airway Glands in CF Lung Disease$369,849
R01 · FY2006 · HL · contact PI
Physiology and Molecular Biology of Lung Water Transport$332,864
R01 · FY2006 · HL · contact PI
Application of Novel Optical Methods to Cell Dynamics$327,895
R01 · FY2006 · EB · contact PI
Functional Role of Aquaporins in Eye Physiology$295,880
R01 · FY2006 · EY · contact PI
CORE--HIGH-THROUGHPUT SCREENING$181,800
P30 · FY2006 · DK · contact PI
CORE--MOUSE MODELS$83,325
P30 · FY2006 · DK · contact PI
Novel small-molecule therapies for CF$1,103,274
P30 · FY2005 · DK
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$527,334
R37 · FY2005 · DK
Role of ASL and Airway Glands in CF Lung Disease$378,750
R01 · FY2005 · HL
Physiology and Molecular Biology of Lung Water Transport$340,875
R01 · FY2005 · HL
Application of Novel Optical Methods to Cell Dynamics$335,921
R01 · FY2005 · EB
Functional Role of Aquaporins in Eye Physiology$303,000
R01 · FY2005 · EY
CORE--HIGH-THROUGHPUT SCREENING$181,800
P30 · FY2005 · DK
PILOT &FEASIBILITY PROGRAM$151,500
P30 · FY2005 · DK
CORE--MOUSE MODELS$83,325
P30 · FY2005 · DK
ADMINISTRATIVE COMPONENT$45,450
P30 · FY2005 · DK
RESEARCH BASE$38,644
P30 · FY2005 · DK
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$566,094
R37 · FY2004 · DK
Role of ASL and Airway Glands in CF Lung Disease$378,750
R01 · FY2004 · HL
Physiology and Molecular Biology of Lung Water Transport$340,875
R01 · FY2004 · HL
Application of Novel Optical Methods to Cell Dynamics$336,050
R01 · FY2004 · EB
Functional Role of Aquaporins in Eye Physiology$303,000
R01 · FY2004 · EY
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$396,707
R37 · FY2003 · DK
Role of ASL and Airway Glands in CF Lung Disease$378,750
R01 · FY2003 · HL
Application of Novel Optical Methods to Cell Dynamics$336,172
R01 · FY2003 · EB
Functional Role of Aquaporins in Eye Physiology$303,000
R01 · FY2003 · EY
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$389,216
R37 · FY2002 · DK
Application of Novel Optical Methods to Cell Dynamics$335,462
R01 · FY2002 · EB
Functional Role of Aquaporins in Eye Physiology$301,333
R01 · FY2002 · EY
PHYSIOLOGY AND MOLECULAR BIOLOGY OF LUNG WATER TRANSPORT$286,986
R01 · FY2002 · HL
SYNTHESIS OF FLUORESCENT PROBES FOR CELL STUDIES$0
P41 · FY2002 · RR
ASL PHYSIOLOGY STUDIED BY NOVEL FLUORESCENCE METHODS$0
P50 · FY2002 · HL
IDENTIFICATION OF RECOMBINANT AQUAPORINS$0
P41 · FY2002 · RR
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$381,942
R37 · FY2001 · DK
PHYSIOLOGY AND MOLECULAR BIOLOGY OF LUNG WATER TRANSPORT$281,709
R01 · FY2001 · HL
APPLICATION OF NOVEL OPTICAL METHODS TO CELL DYNAMICS$249,858
R01 · FY2001 · DK
IDENTIFICATION OF RECOMBINANT AQUAPORINS$0
P41 · FY2001 · RR
ASL PHYSIOLOGY STUDIED BY NOVEL FLUORESCENCE METHODS$0
P50 · FY2001 · HL
SYNTHESIS OF FLUORESCENT PROBES FOR CELL STUDIES$0
P41 · FY2001 · RR
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$301,129
R37 · FY2000 · DK
PHYSIOLOGY AND MOLECULAR BIOLOGY OF LUNG WATER TRANSPORT$276,561
R01 · FY2000 · HL
APPLICATION OF NOVEL OPTICAL METHODS TO CELL DYNAMICS$244,496
R01 · FY2000 · DK
ASL PHYSIOLOGY STUDIED BY NOVEL FLUORESCENCE METHODS$180,910
P50 · FY2000 · HL
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIA$73,750
R37 · FY2000 · DK
IDENTIFICATION OF RECOMBINANT AQUAPORINS$9,880
P41 · FY2000 · RR
SYNTHESIS OF FLUORESCENT PROBES FOR CELL STUDIES$9,880
P41 · FY2000 · RR